Argenica Therapeutics' Phase 2 stroke drug trial hits major milestone

By Proactive Investors / November 06, 2024 / www.youtube.com / Article Link


Argenica Therapeutics Ltd (ASX:AGN, OTC:OTCMKTS: AGNTF) CEO and managing director, Dr Liz Dallimore talked with ...

Recent News

Major producers and most of TSXV gold see strong gains
March 03, 2026 / www.canadianminingreport.com

Big Gold production declining, revenue surging, costs flat
February 23, 2026 / www.canadianminingreport.com

Gold stocks rise with majors outpaced by juniors
February 23, 2026 / www.canadianminingreport.com

Agnico Eagle's production dip and higher costs offset by jump in gold
February 17, 2026 / www.canadianminingreport.com

Barrick, Agnico Eagle report extremely strong Q4/25 results
February 17, 2026 / www.canadianminingreport.com
See all >
Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok